Kringle Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Jul '25 Jul 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2019 - 2020
Market Capitalization	3,419	5,760	4,318	2,421	3,919	-	Upgrade
Market Cap Growth	74.14%	33.41%	78.32%	-38.21%	-	-	Upgrade
Enterprise Value	1,532	3,304	1,936	-27	1,690	-	Upgrade
Last Close Price	500.00	847.00	798.00	450.00	907.00	-	Upgrade
PS Ratio	47.48	72.00	62.58	6.19	13.56	-	Upgrade
PB Ratio	2.13	2.73	2.14	0.87	1.56	-	Upgrade
P/TBV Ratio	2.13	2.73	2.14	0.87	1.56	-	Upgrade
P/OCF Ratio	-	-	-	161.42	-	-	Upgrade
EV/Sales Ratio	21.28	41.30	28.05	-	5.85	-	Upgrade
Asset Turnover	0.03	0.03	0.02	0.13	0.12	0.36	Upgrade
Inventory Turnover	-	-	-	0.27	0.39	-	Upgrade
Quick Ratio	12.38	18.52	10.61	17.43	17.47	14.03	Upgrade
Current Ratio	14.61	21.52	12.52	19.80	20.74	14.77	Upgrade
Return on Equity (ROE)	-45.90%	-36.63%	-35.52%	-12.50%	-12.83%	-9.73%	Upgrade
Return on Assets (ROA)	-23.14%	-19.00%	-19.07%	-9.11%	-8.98%	-8.27%	Upgrade
Return on Capital (ROIC)	-30.63%	-24.74%	-23.11%	-10.06%	-9.53%	-8.94%	Upgrade
Earnings Yield	-26.39%	-13.13%	-19.78%	-13.67%	-7.68%	-	Upgrade
Buyback Yield / Dilution	-17.90%	-18.72%	-11.00%	-16.91%	-7422.44%	94.70%	Upgrade

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.